Form 8-K - Current report:
SEC Accession No. 0001104659-25-003715
Filing Date
2025-01-15
Accepted
2025-01-15 15:09:24
Documents
13
Period of Report
2024-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253448d1_8k.htm   iXBRL 8-K 24216
  Complete submission text file 0001104659-25-003715.txt   194960

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA trvn-20241231.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20241231_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20241231_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT tm253448d1_8k_htm.xml XML 3567
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 25532704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)